August 27, 2014 2:57 PM ET

Biotechnology

Company Overview of Lysosomal Therapeutics Inc.

Company Overview

Lysosomal Therapeutics Inc. is engaged in small-molecule research and development in the field of neurodegenerative diseases to discover new drugs for patients with severe neurological diseases. The company provides services to target Gaucher-related neurodegeneration, Parkinson’s disease, and other synucleinopathies. Lysosomal Therapeutics Inc. was incorporated in 2011 and is headquartered in Cambridge, Massachusetts.

19 Blackstone Street

Cambridge, MA 02139

United States

Founded in 2011

Phone:

617-913-0166

Key Executives for Lysosomal Therapeutics Inc.

Founder
Founder and Chairman of The Board
Age: 68
Scientific Founder and Chairman of Scientific Advisory Board
Scientific Founder
Founder
Age: 68
Compensation as of Fiscal Year 2014.

Lysosomal Therapeutics Inc. Key Developments

Lysosomal Therapeutics Inc Presents at Boston Biotech BD Boston Conference, Mar-26-2014 03:30 PM

Lysosomal Therapeutics Inc Presents at Boston Biotech BD Boston Conference, Mar-26-2014 03:30 PM. Venue: Four Seasons Hotel, 200 Boylston Street, Boston, MA 02116, United States. Speakers: Kees Been.

Lysosomal Therapeutics Inc Presents at Boston Biotech Conferences LLC's East/West CEO Conference, Jan-12-2014 02:20 PM

Lysosomal Therapeutics Inc Presents at Boston Biotech Conferences LLC's East/West CEO Conference, Jan-12-2014 02:20 PM. Venue: Four Seasons Hotel, San Francisco, California, United States. Speakers: Kees Been.

Similar Private Companies By Industry

Company Name Region
OyaGen, Inc. United States
Hemoglobin Oxygen Therapeutics LLC United States
ReVas United States
Novan, Inc. United States
Kadmus Pharmaceuticals, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
April 30, 2014
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Lysosomal Therapeutics Inc., please visit www.lysosomaltx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.